Terms: = Leukemia AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Diagnosis
114 results:
1. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis.
Ren W; Wan H; Own SA; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini RM; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
Leukemia; 2024 Mar; 38(3):610-620. PubMed ID: 38158444
[TBL] [Abstract] [Full Text] [Related]
2. Renomegaly and acute kidney injury as primary manifestations of non-Hodgkin's lymphoma: a report of three cases.
Bai Y; Zheng Y; Zhang Q; Jiang Q; Diao Z; Guo W; Liu S; Liu W
Diagn Pathol; 2023 Dec; 18(1):133. PubMed ID: 38066507
[TBL] [Abstract] [Full Text] [Related]
3. Poor Outcome of Adult T-Cell leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers.
Saeed H; Sandoval-Sus J; Castillo-Tokumori F; Dong N; Pullukkara JJ; Boisclair S; Brahim A; Walker D; Bridgellal S; Zhang L; Sokol L
Oncol Res Treat; 2023; 46(11):459-465. PubMed ID: 37844559
[TBL] [Abstract] [Full Text] [Related]
4. [Risk factors for leukemia transformation in patients with myelodysplastic syndromes].
Zhao SY; Xu ZF; Qin TJ; Qu SQ; Li CW; Jia YJ; Pan LJ; Li B; Gao QY; Jiao M; Huang HJ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Oct; 43(10):818-825. PubMed ID: 36709195
[No Abstract] [Full Text] [Related]
5. Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
Zimmermann H; Koenecke C; Dreyling MH; Pott C; Dührsen U; Hahn D; Meidenbauer N; Hauser IA; Rummel MJ; Wolf D; Heuser M; Schmidt C; Schlattmann P; Ritgen M; Siebert R; Oschlies I; Anagnostopoulos I; Trappe RU
Leukemia; 2022 Oct; 36(10):2468-2478. PubMed ID: 35974101
[TBL] [Abstract] [Full Text] [Related]
6. Colonic infiltration of chronic lymphocytic leukemia with Hodgkin Reed Sternberg-like cells.
Nova-Camacho LM; Val-Carreres Castellote A; Riego Repullo V
Rev Esp Enferm Dig; 2022 Aug; 114(8):510-511. PubMed ID: 35297262
[TBL] [Abstract] [Full Text] [Related]
7. [Discordant lymphoma of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified in a human T-cell leukemia virus type-I carrier].
Sumiya C; Kagoo T; Yokoyama A; Yano T; Ueno H
Rinsho Ketsueki; 2021; 62(9):1400-1405. PubMed ID: 34615800
[TBL] [Abstract] [Full Text] [Related]
8. Indeterminate and oncogenic potential: CHIP vs chop mutations in AML with NPM1 alteration.
Cappelli LV; Meggendorfer M; Baer C; Nadarajah N; Hutter S; Jeromin S; Dicker F; Kern W; Haferlach T; Haferlach C; Höllein A
Leukemia; 2022 Feb; 36(2):394-402. PubMed ID: 34376804
[TBL] [Abstract] [Full Text] [Related]
9. Real World Treatment Practices for Mantle Cell Lymphoma in Japan: An Observational Database Research Study (CLIMBER-DBR).
Izutsu K; Suzumiya J; Takizawa J; Fukase K; Nakamura M; Jinushi M; Nagai H
J Clin Exp Hematop; 2021 Sep; 61(3):135-144. PubMed ID: 34092722
[TBL] [Abstract] [Full Text] [Related]
10. Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.
Imoto N; Koyama D; Sugiura I; Kurahashi S
Medicine (Baltimore); 2021 Feb; 100(5):e24457. PubMed ID: 33592897
[TBL] [Abstract] [Full Text] [Related]
11. Reversal of Resistance to Anti-CD20 Antibody Therapies: Targeting Intracellular Resistant Factors.
Navasardyan I; Bonavida B
Crit Rev Oncog; 2020; 25(3):275-290. PubMed ID: 33463946
[TBL] [Abstract] [Full Text] [Related]
12. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment.
Yevstakhevych YL; Vyhovska YI; Yevstakhevych IY; Vyhovska OY; Pelenyo NV; Semerak MM; Novak VL; Loginsky VE
Exp Oncol; 2020 Dec; 42(4):318-323. PubMed ID: 33355861
[TBL] [Abstract] [Full Text] [Related]
13. Cutaneous plaque in adult T cell leukemia/lymphoma: A case report.
Lei CS; Jiang Q; Yu Q; Qiu L
Medicine (Baltimore); 2020 Dec; 99(50):e23491. PubMed ID: 33327284
[TBL] [Abstract] [Full Text] [Related]
14. Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries.
Chiattone C; Gomez-Almaguer D; Pavlovsky C; Tuna-Aguilar EJ; Basquiera AL; Palmer L; de Farias DLC; da Silva Araujo SS; Galvez-Cardenas KM; Gomez Diaz A; Lin JH; Chen YW; Machnicki G; Mahler M; Parisi L; Barreyro P
Hematology; 2020 Dec; 25(1):366-371. PubMed ID: 33095117
[TBL] [Abstract] [Full Text] [Related]
15. Subcutaneous Masses as an Unusual Manifestation of Relapse in a Case of Atypical Chronic Lymphocytic leukemia with Prolymphocytoid Transformation and Complex Karyotype: A Diagnostic Dilemma and Treatment Challenge.
Aldapt MB; Soliman D; Szabados L; Sharaf Eldean MZ; Shwaylia HM; Abdulla MAJ; Yassin MA
Am J Case Rep; 2020 May; 21():e920411. PubMed ID: 32388531
[TBL] [Abstract] [Full Text] [Related]
16. Occurrence of lymphoplasmacytic lymphoma in a chronic myeloid leukemia patient following long-term treatment with tyrosine kinase inhibitors: A case report.
Lee CH; Jeon SY; Yhim HY; Jang KY; Kwak JY
Medicine (Baltimore); 2020 May; 99(19):e19962. PubMed ID: 32384445
[TBL] [Abstract] [Full Text] [Related]
17. Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials.
Al-Sawaf O; Robrecht S; Bahlo J; Fink AM; Cramer P; V Tresckow J; Lange E; Kiehl M; Dreyling M; Ritgen M; Dürig J; Tausch E; Schneider C; Stilgenbauer S; Wendtner CM; Fischer K; Goede ; Hallek M; Eichhorst B
Leukemia; 2021 Jan; 35(1):169-176. PubMed ID: 32203141
[TBL] [Abstract] [Full Text] [Related]
18. Non-Hodgkin lymphoma after liver and kidney transplantation in children. Experience from one center.
Dembowska-Bagińska B; Wakulińska A; Daniluk I; Teisseyre J; Jankowska I; Czubkowski P; Grenda R; Jarmużek W; Grajkowska W; Małdyk J; Kaliciński P
Adv Clin Exp Med; 2020 Feb; 29(2):197-202. PubMed ID: 32154678
[TBL] [Abstract] [Full Text] [Related]
19. VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysis.
Fuji S; Yamaguchi T; Inoue Y; Utsunomiya A; Moriuchi Y; Owatari S; Miyagi T; Sawayama Y; Otsuka E; Yoshida SI; Fukuda T
Bone Marrow Transplant; 2019 Sep; 54(9):1399-1405. PubMed ID: 30664725
[TBL] [Abstract] [Full Text] [Related]
20. [Analysis of Factors Influencing Prognosis of 87 Adults with Ph Chromosome Negative ALL].
Li J; Zhang ZB; Liu ZR; Yang M; Nie YX; Wu MM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1011-1015. PubMed ID: 30111399
[TBL] [Abstract] [Full Text] [Related]
[Next]
